Home/Filings/4/0001641172-25-005109
4//SEC Filing

Kocak Ron 4

Accession 0001641172-25-005109

CIK 0001574094other

Filed

Apr 15, 8:00 PM ET

Accepted

Apr 16, 5:18 PM ET

Size

5.8 KB

Accession

0001641172-25-005109

Insider Transaction Report

Form 4
Period: 2025-04-14
Kocak Ron
VP, Controller and PAO
Transactions
  • Award

    Stock Option

    2025-04-14+166,400166,400 total
    Exercise: $0.84Common Stock (166,400 underlying)
Footnotes (1)
  • [F1]On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted an incentive stock option to purchase up to 166,400 shares of the Issuer's common stock, with such option vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on April 14, 2035.

Documents

1 file

Issuer

RenovoRx, Inc.

CIK 0001574094

Entity typeother

Related Parties

1
  • filerCIK 0002011160

Filing Metadata

Form type
4
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 5:18 PM ET
Size
5.8 KB